(Q45937675)

18 December 2017

title

Intermittent androgen deprivation for clinically localized prostate cancer: initial experience. (English)

1 reference

18 December 2017

1 reference

Grossfeld GD

1

1 reference

18 December 2017

Small EJ

series ordinal

2

1 reference

18 December 2017

Carroll PR

series ordinal

3

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

18 December 2017

published in

Urology

1 reference

18 December 2017

volume

51

1 reference

18 December 2017

page(s)

137-144

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Intermittent endocrine therapy for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900488-3

7 January 2021

10.1016/S0090-4295(97)00488-3

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

9457309

1 reference

18 December 2017